Skip to main content

Advertisement

Log in

Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The prostate cancer impacts on the future life of survivors. The complexity of sexual health problems in prostate cancer survivors is underestimated or often reduced to the erectile dysfunction. Especially, factors influencing sexual desire of patients have to be more explored. This study aims to describe the therapeutic management of patients with prostate cancer and assess their sexual desire 2 years after diagnosis.

Methods

This study is part of the National VICAN survey (Vie après le CANcer) implemented in France in 2012. This analysis was performed on a population of 414 men who had prostate cancer. The questionnaire dealt with several topics including socioeconomic status, treatments received, and sexual desire.

Results

Prostatectomy (42.8%), radiotherapy + hormonotherapy (17.6%), and radiotherapy alone (12.8%) were the main treatments used. 41.3% of men stated that their sexual desire was all gone since disease. The “satisfying” perceived financial situation was significantly associated to a sexual desire loss (p = 0.008). Radiotherapy + hormonotherapy treatment only is significantly associated with a loss of sexual desire (P = 0.003).

Conclusions

Two years after diagnosis, the sexual desire of prostate cancer survivors is deteriorated with the cancer experience. However, clinical characteristics do not seem to be decisive unlike a “satisfying” financial situation. Research about the impact of socio economics characteristics on sexual health should probably be engaged. Programs have to be developed in France to have personalized sexual support progressed for survivors and take spouses into consideration in this context.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Institut National du Cancer (2014) Implication des urologues en cancérologie. Collection études et enquêtes, ouvrage collectif

  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  3. Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, Johansson E, Stattin P, Fransson P (2016) Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int 117:E36–E45

    Article  CAS  PubMed  Google Scholar 

  4. Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA et al (2016) Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int 118:372–378

    Article  PubMed  Google Scholar 

  5. Droupy S, Al SB, Lechevallier E, Colson MH, Giuliano F (2013) Sexuality and prostate cancer. Prog Urol 23:696–711

    Article  CAS  PubMed  Google Scholar 

  6. “La vie deux ans après un diagnostic de cancer - De l’annonce à l’après cancer”, collection Etudes et enquêtes, INCa, juin 2014

  7. Perz J, Ussher JM, Gilbert E (2013) Constructions of sex and intimacy after cancer (2013) Q methodology study of people with cancer, their partners, and health professionals. BMC Cancer 13:270

    Article  PubMed  PubMed Central  Google Scholar 

  8. Montgomery KA (2008) Sexual desire disorders. Psychiatry (Edgmont) 5:50–55

    Google Scholar 

  9. Colson MH, Lemaire A, Pinton P, Hamidi K, Klein P (2006) Sexual behaviors and mental perception, satisfaction and expectations of sex life in men and women in France. J Sex Med 3:121–131

    Article  PubMed  Google Scholar 

  10. Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA (2001) The development of erectile dysfunction in men treated for prostate cancer. J Urol 165:430–435

    Article  CAS  PubMed  Google Scholar 

  11. Dahn JR, Penedo FJ, Gonzalez JS, Esquiabro M, Antoni MH, Roos BA, Schneiderman N (2004) Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology 63:273–277

    Article  PubMed  Google Scholar 

  12. Levine SB (2002) Reexploring the concept of sexual desire. J Sex Marital Ther 28:39–51

    Article  PubMed  Google Scholar 

  13. Levine SB (2003) The nature of sexual desire a clinician’s perspective. Arch Sex Behav 32:279–285

    Article  PubMed  Google Scholar 

  14. Carvalho J, Nobre P (2011) Biopsychosocial determinants of men's sexual desire: testing an integrative model. J Sex Med 8:754–763

    Article  PubMed  Google Scholar 

  15. Dosch A, Rochat L, Ghisletta P, Favez N, Van der Linden M (2016) Psychological factors involved in sexual desire, sexual activity, and sexual satisfaction: a multi-factorial perspective. Arch Sex Behav 45:2029–2045

    Article  PubMed  Google Scholar 

  16. Beck AM, Robinson JW, Carlson LE (2009) Sexual intimacy in heterosexual couples after prostate cancer treatment: what we know and what we still need to learn. Urol Oncol 27:137–143

    Article  PubMed  Google Scholar 

  17. Tucker SR, Speer SA, Peters S (2016) Development of an explanatory model of sexual intimacy following treatment for localised prostate cancer: a systematic review and meta-synthesis of qualitative evidence. Soc Sci Med 163:80–88

    Article  PubMed  Google Scholar 

  18. Harrington JM (2011) Implications of treatment on body image and quality of life. Semin Oncol Nurs 27:290–299

    Article  PubMed  Google Scholar 

  19. Bouhnik AD, Bendiane MK, Cortaredona S, Teyssier LS, Rey D, Berenger C et al (2015) The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 5:e005971

    Article  PubMed  PubMed Central  Google Scholar 

  20. Burdine JN, Felix MR, Abel AL, Wiltraut CJ, Musselman YJ (2000) The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res 35:885–904

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450

    Article  CAS  PubMed  Google Scholar 

  22. Lenormand F (2005) Le système d’information de l’assurance maladie, le SNIIR-AM et les échantillons de bénéficiaires. Courr Statistiques Insee 113–114:33–51

    Google Scholar 

  23. Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE (2001) Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 19:2788–2796

    Article  CAS  PubMed  Google Scholar 

  24. Lindau ST, Gavrilova N (2010) Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 340:c810

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bortz WM, Wallace DH, Wiley D (1999) Sexual function in 1,202 aging males: differentiating aspects. J Gerontol A Biol Sci Med Sci 54:M237–M241

    Article  PubMed  Google Scholar 

  26. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2003) Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139:161–168

    Article  PubMed  Google Scholar 

  27. McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E et al (2015) Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine. J Sex Med 2016(13):135–143

    Google Scholar 

  28. Sharp L, Carsin AE, Timmons A (2013) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology 22:745–755

    Article  PubMed  Google Scholar 

  29. Ben Charif A, Bouhnik AD, Courbière B, Rey D, Préau M, Bendiane MK, Peretti-Watel P, Mancini J (2016) Sexual health problems in French cancer survivors 2 years after diagnosis - the national VICAN survey. J Cancer Surviv 10:600–609

    Article  PubMed  Google Scholar 

  30. Bober SL, Varela VS (2012) Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol 30:3712–3719

    Article  PubMed  Google Scholar 

  31. Ussher JM, Perz J, Gilbert E, Wong WK, Mason C, Hobbs K et al (2013) Talking about sex after cancer: a discourse analytic study of health care professional accounts of sexual communication with patients. Psychol Health 28:1370–1390

    Article  PubMed  Google Scholar 

  32. Chung E, Brock G (2013) Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med 10(Suppl 1):102–111

    Article  PubMed  Google Scholar 

  33. Badr H, Taylor CL (2009) Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 18:735–746

    Article  PubMed  PubMed Central  Google Scholar 

  34. Eilat-Tsanani S, Tabenkin H, Shental J, Elmalah I, Steinmetz D (2013) Patients’ perceptions of radical prostatectomy for localized prostate cancer: a qualitative study. Isr Med Assoc J 15:153–157

    PubMed  Google Scholar 

  35. McConkey R (2015) Effect of erectile dysfunction following prostate cancer treatment. Nurs Stand 30:38–44

    Article  PubMed  Google Scholar 

  36. Flynn KE, Jeffery DD, Keefe FJ, Porter LS, Shelby RA, Fawzy MR, Gosselin TK, Reeve BB, Weinfurt KP (2011) Sexual functioning along the cancer continuum: focus group results from the patient-reported outcomes measurement information system (PROMIS(R)). Psychooncology 20:378–386

    Article  PubMed  Google Scholar 

  37. Corona G, Isidori AM, Aversa A, Burnett AL, Maggi M (2016) Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 13:317–337

    Article  PubMed  Google Scholar 

  38. Corona G, Baldi E, Maggi M (2011) Androgen regulation of prostate cancer: where are we now? J Endocrinol Investig 34:232–243

    Article  CAS  Google Scholar 

  39. Hyde MK, Zajdlewicz L, Wootten AC, Nelson CJ, Lowe A, Dunn J, Chambers SK (2016) Medical help-seeking for sexual concerns in prostate cancer survivors. Sex Med 4:e7–e17

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ben CA, Bouhnik AD, Courbiere B, Rey D, Preau M, Bendiane MK et al (2016) Patient discussion about sexual health with health care providers after cancer-a national survey. J Sex Med 13:1686–1694

    Article  Google Scholar 

  41. Wittmann D, Northouse L, Foley S, Gilbert S, Wood DP Jr, Balon R et al (2009) The psychosocial aspects of sexual recovery after prostate cancer treatment. Int J Impot Res 21:99–106

    Article  CAS  PubMed  Google Scholar 

  42. Speer SA, Tucker SR, McPhillips R, Peters S (2017) The clinical communication and information challenges associated with the psychosexual aspects of prostate cancer treatment. Soc Sci Med 185:17–26

    Article  PubMed  Google Scholar 

  43. Flynn KE, Reese JB, Jeffery DD, Abernethy AP, Lin L, Shelby RA, Porter LS, Dombeck CB, Weinfurt KP (2012) Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 21:594–601

    Article  PubMed  Google Scholar 

  44. O’Shaughnessy PK, Laws TA, Esterman AJ (2015) The prostate cancer journey: results of an online survey of men and their partners. Cancer Nurs 38:E1–E12

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the members of the VICAN Group: Thomas Aparicio, Emmanuel Babin, François Beck, Daniel Benamouzig, Robert Benamouzig, Marc-Karim Bendiane, Cyril Bérenger, Dominique Bessette, Anne-Déborah Bouhnik, Philippe-Jean Bousquet, Marie-Claude Cabanel-Gicquel, Michèle Chantry, Claire Chauvet, Jacqueline Clavel, Sébastien Cortaredona, Véronique Danguy, Sarah Dauchy, Mario Di Palma, Michel Dorval, Jean-Baptiste Herbet, Laetitia Huiart, Xavier Joutard, Marianick Lambert, Anne-Gaëlle Le Corroller-Soriano, Stéphane Legleye, Julien Mancini, Jean-François Morère, Nora Moumjid-Ferdjaoui, Hermann Nabi, Alain Paraponaris, Patrick Peretti-Watel, Graziella Pourcel, Marie Préau, Frédérique Retornaze, Dominique Rey, Benoît Riandey, Laetitia Rollin, Luis Sagaon-Teyssier, Valérie Seror, Archana Singh-Manoux, Catherine Thieblemont, and Patricia Verney.

Funding

The VICAN study was funded by the French National Institute of Cancer (Institut National du Cancer, INCa) “Contrat de recherche et développement no 05-2011.”

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Magali Girodet.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee (the CCTIRS: Comité Consultatif sur le Traitement de l’Information en Matière de Recherche dans le Domaine de la Santé, study registered under no 11-143, the ISP: Institute of Public Health, study registered under no C11–63 and the CNIL: French Commission on Individual Data Protection and Public Liberties, study registered under no 911290) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the VICAN study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Girodet, M., Bouhnik, AD., Mancini, J. et al. Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey). Support Care Cancer 27, 2517–2524 (2019). https://doi.org/10.1007/s00520-018-4536-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-018-4536-z

Keywords

Navigation